603 Phase II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): big ten cancer research consortium (BTCRC-LUN17–127) study

• Jyoti Malhotra,
• Alberto Chiappori,
• Salma K Jabbour,
• Chunxia Chen,
• Naomi Fujioka,
• Nasser H Hanna,
• Lawrence E Feldman,
• Malini Patel,
• Dirk Moore

Affiliations

Jyoti Malhotra

1City of Hope Cancer Center, Irvine, CA, USA

Alberto Chiappori

1Moffitt Cancer Center, Tampa, FL, USA

Salma K Jabbour

Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA

Chunxia Chen

School of Life Sciences, Zhengzhou University, Zhengzhou, China

Naomi Fujioka

2Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA

Nasser H Hanna

IU Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, USA

Lawrence E Feldman

5University of Illinois College of Medicine, Chicago, IL, USA

Malini Patel

6Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA

Dirk Moore

6Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA